...
nvcr-img

Novocure Ltd, Common Stock

NVCR

NSQ

$28.65

+$0.69

(2.47%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.03B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
921.55K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.70
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$11.66 L
$32.6 H
$28.65

About Novocure Ltd, Common Stock

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameNVCRSectorS&P500
1-Week Return-4.02%-1.95%0.69%
1-Month Return57.5%-3.36%1.53%
3-Month Return72.49%-6.93%11.27%
6-Month Return33.5%-1.83%13.49%
1-Year Return132.74%8.53%31.62%
3-Year Return-67.36%7.58%30.33%
5-Year Return-64.76%44.7%93.83%
10-Year Return56.73%103.96%195.13%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue351.32M494.37M535.03M537.84M509.34M[{"date":"2019-12-31","value":65.32,"profit":true},{"date":"2020-12-31","value":91.92,"profit":true},{"date":"2021-12-31","value":99.48,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.7,"profit":true}]
Cost of Revenue88.61M106.50M114.88M114.87M128.28M[{"date":"2019-12-31","value":69.07,"profit":true},{"date":"2020-12-31","value":83.02,"profit":true},{"date":"2021-12-31","value":89.55,"profit":true},{"date":"2022-12-31","value":89.54,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit262.71M387.87M420.15M422.97M381.06M[{"date":"2019-12-31","value":62.11,"profit":true},{"date":"2020-12-31","value":91.7,"profit":true},{"date":"2021-12-31","value":99.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":90.09,"profit":true}]
Gross Margin74.78%78.46%78.53%78.64%74.81%[{"date":"2019-12-31","value":95.09,"profit":true},{"date":"2020-12-31","value":99.76,"profit":true},{"date":"2021-12-31","value":99.86,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":95.13,"profit":true}]
Operating Expenses263.63M357.46M464.49M512.50M613.93M[{"date":"2019-12-31","value":42.94,"profit":true},{"date":"2020-12-31","value":58.23,"profit":true},{"date":"2021-12-31","value":75.66,"profit":true},{"date":"2022-12-31","value":83.48,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(914.00K)21.25M(44.33M)(89.52M)(232.87M)[{"date":"2019-12-31","value":-4.3,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-208.62,"profit":false},{"date":"2022-12-31","value":-421.26,"profit":false},{"date":"2023-12-31","value":-1095.81,"profit":false}]
Total Non-Operating Income/Expense(15.39M)(27.25M)(11.45M)18.88M83.06M[{"date":"2019-12-31","value":-18.53,"profit":false},{"date":"2020-12-31","value":-32.8,"profit":false},{"date":"2021-12-31","value":-13.79,"profit":false},{"date":"2022-12-31","value":22.73,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(8.82M)18.10M(52.08M)(81.85M)(191.74M)[{"date":"2019-12-31","value":-48.75,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-287.68,"profit":false},{"date":"2022-12-31","value":-452.14,"profit":false},{"date":"2023-12-31","value":-1059.22,"profit":false}]
Income Taxes(1.59M)(1.71M)6.28M10.69M15.30M[{"date":"2019-12-31","value":-10.42,"profit":false},{"date":"2020-12-31","value":-11.15,"profit":false},{"date":"2021-12-31","value":41.01,"profit":true},{"date":"2022-12-31","value":69.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(7.23M)19.81M(58.35M)(92.53M)(207.04M)[{"date":"2019-12-31","value":-36.5,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-294.58,"profit":false},{"date":"2022-12-31","value":-467.15,"profit":false},{"date":"2023-12-31","value":-1045.25,"profit":false}]
Income From Continuous Operations(7.23M)19.81M(58.35M)(92.53M)(207.04M)[{"date":"2019-12-31","value":-36.5,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-294.58,"profit":false},{"date":"2022-12-31","value":-467.15,"profit":false},{"date":"2023-12-31","value":-1045.25,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(7.23M)19.81M(58.35M)(92.53M)(207.04M)[{"date":"2019-12-31","value":-36.5,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-294.58,"profit":false},{"date":"2022-12-31","value":-467.15,"profit":false},{"date":"2023-12-31","value":-1045.25,"profit":false}]
EPS (Diluted)(0.08)0.19(0.56)(0.88)(1.95)[{"date":"2019-12-31","value":-42.11,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-294.74,"profit":false},{"date":"2022-12-31","value":-463.16,"profit":false},{"date":"2023-12-31","value":-1026.32,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

NVCR
Cash Ratio 1.31
Current Ratio 1.49
Quick Ratio 1.44

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NVCR
ROA (LTM) -7.93%
ROE (LTM) -39.71%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NVCR
Debt Ratio Lower is generally better. Negative is bad. 0.70
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.30

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NVCR
Trailing PE NM
Forward PE 909.09
P/S (TTM) 5.24
P/B 8.39
Price/FCF NM
EV/R 4.74
EV/Ebitda NM
PEG NM

FAQs

What is Novocure Ltd share price today?

Novocure Ltd (NVCR) share price today is $28.65

Can Indians buy Novocure Ltd shares?

Yes, Indians can buy shares of Novocure Ltd (NVCR) on Vested. To buy Novocure Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NVCR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Novocure Ltd be purchased?

Yes, you can purchase fractional shares of Novocure Ltd (NVCR) via the Vested app. You can start investing in Novocure Ltd (NVCR) with a minimum investment of $1.

How to invest in Novocure Ltd shares from India?

You can invest in shares of Novocure Ltd (NVCR) via Vested in three simple steps:

  • Click on Sign Up or Invest in NVCR stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Novocure Ltd shares
What is Novocure Ltd 52-week high and low stock price?

The 52-week high price of Novocure Ltd (NVCR) is $32.6. The 52-week low price of Novocure Ltd (NVCR) is $11.66.

What is Novocure Ltd price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Novocure Ltd (NVCR) is

What is Novocure Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Novocure Ltd (NVCR) is 8.39

What is Novocure Ltd dividend yield?

The dividend yield of Novocure Ltd (NVCR) is 0.00%

What is the Market Cap of Novocure Ltd?

The market capitalization of Novocure Ltd (NVCR) is $3.03B

What is Novocure Ltd’s stock symbol?

The stock symbol (or ticker) of Novocure Ltd is NVCR

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top